The Development of a Cognitive Scale for Functional Bowel Disorders

Toner, Brenda B.; Stuckless, Noreen; Ali, Alisha; Downie, Fiona; Emmott, Shelagh; Akman, Donna

doi:10.1097/00006842-199807000-00017

Cited by 78 publications

(57 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Psychometric analysis produced a 25-item scale with high reliability and validity and minimal social desirability contamination. No steady scale components were found for the Dutch version [29]. The total score ranges from 31 to 217, with higher scores reflecting more dysfunctional thoughts.…”

Section: Measures Questionnairesmentioning

confidence: 89%

“…The Cognitive Scale for Functional Bowel Disorders (CSFBD) is an illness-specific scale that measures GI symptom-related dysfunctional cognitions commonly experienced by IBS patients [29]. The scale items were derived from Automatic Thought Diaries of IBS patients and then categorized into the themes: anxiety, control, pain, perfectionism, anger/frustration, self-efficacy, social approval, embarrassment/shame, heightened sensitivity to social rules and norms, and selfnurturance.…”

Section: Measures Questionnairesmentioning

confidence: 99%

See 1 more Smart Citation

Intervening on cognitions and behavior in irritable bowel syndrome: A feasibility trial using PDAs

Oerlemans

Cranenburgh

Herremans

et al. 2011

Journal of Psychosomatic Research

View full text Add to dashboard Cite

A cognitive-behavioral intervention on pocket-type computers appears feasible and efficacious for improving IBS-related complaints and cognitions in the short-term. The intervention group improved on several aspects, but most on catastrophizing thoughts, and these improvements even persisted after 3 months. Future studies should focus on unravelling the effective components of this innovative e-health intervention.

show abstract

Section: Measures Questionnairesmentioning

confidence: 89%

Section: Measures Questionnairesmentioning

confidence: 99%

Intervening on cognitions and behavior in irritable bowel syndrome: A feasibility trial using PDAs

Oerlemans

Cranenburgh

Herremans

et al. 2011

Journal of Psychosomatic Research

View full text Add to dashboard Cite

show abstract

“…20 The items are rated from 1 "strongly disagree" to 7 "strongly agree," and are summed to make a total score.…”

Section: Cognitive Scale For Functional Bowel Disordersmentioning

confidence: 99%

Balance of Autonomic Nervous System Predicts Who Benefits from a Self-management Intervention Program for Irritable Bowel Syndrome

Jarrett

Cain

Barney

et al. 2015

J Neurogastroenterol Motil

View full text Add to dashboard Cite

Background/AimsTo determine if potential biomarkers can be used to identify subgroups of people with irritable bowel syndrome (IBS) who will benefit the most or the least from a comprehensive self-management (CSM) intervention. MethodsIn a two-armed randomized controlled trial a CSM (n = 46) was compared to a usual care (n = 46) group with follow-up at 3 and 6 months post randomization. Biomarkers obtained at baseline included heart rate variability, salivary cortisol, interleukin-10 produced by unstimulated peripheral blood mononuclear cells, and lactulose/mannitol ratio. Linear mixed models were used to test whether these biomarkers predicted improvements in the primary outcomes including daily abdominal pain, Gastrointestinal Symptom score and IBS-specific quality of life. ResultsThe nurse-delivered 8-session CSM intervention is more effective than usual care in reducing abdominal pain, reducing Gastrointestinal Symptom score, and enhancing quality of life. Participants with lower nighttime high frequency heart rate variability (vagal modulation) and increased low frequency/high frequency ratio (sympathovagal balance) had less benefit from CSM on abdominal pain. Salivary cortisol, IL-10, and lactulose/mannitol ratio were not statistically significant in predicting CSM benefit. Baseline symptom severity interacts with treatment, namely the benefit of CSM is greater in those with higher baseline symptoms. ConclusionsCognitively-focused therapies may be less effective in reducing abdominal pain in IBS patients with higher sympathetic tone. Whether this a centrally-mediated patient characteristic or related to heightened arousal remains to be determined.

show abstract

“…Although a cognitive scale for functional bowel disorders (FBDs) has been developed to identify the cognitive component of IBS [7], a review of the literature highlighted a lack of studies undertaken to identify IBSrelated behavior. By increasing our awareness of unhelpful behavioral responses in these patients, cognitive behavioral models of IBS may be further developed and refined and cognitive behavioral treatments improved.…”

Section: Introductionmentioning

confidence: 99%

The development of the irritable bowel syndrome-behavioral responses questionnaire

Rème

Darnley

Kennedy

et al. 2010

Journal of Psychosomatic Research

View full text Add to dashboard Cite

The Development of a Cognitive Scale for Functional Bowel Disorders

Cited by 78 publications

References 30 publications

Intervening on cognitions and behavior in irritable bowel syndrome: A feasibility trial using PDAs

Intervening on cognitions and behavior in irritable bowel syndrome: A feasibility trial using PDAs

Balance of Autonomic Nervous System Predicts Who Benefits from a Self-management Intervention Program for Irritable Bowel Syndrome

The development of the irritable bowel syndrome-behavioral responses questionnaire

Contact Info

Product

Resources

About